|
Volumn 61, Issue 7, 1988, Pages 1304-1311
|
Age and dose of chemotherapy as major prognostic factors in a trial of adjuvant therapy of osteosarcoma combining two alternating drug combinations and early prophylactic lung irradiation
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOPHOSPHAMIDE;
DACARBAZINE;
DOXORUBICIN;
FOLINIC ACID;
METHOTREXATE;
MITOMYCIN C;
VINCRISTINE;
ADJUVANT THERAPY;
AGE;
ALLERGIC REACTION;
ALOPECIA;
BONE MARROW TOXICITY;
CARDIOTOXICITY;
CLINICAL ARTICLE;
DYSPNEA;
FEMALE;
HUMAN;
INFECTION;
LUNG RADIOTHERAPY;
MALE;
OSTEOSARCOMA;
PROGNOSIS;
ADOLESCENT;
ADULT;
AGING;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BONE NEOPLASMS;
CHILD;
COMBINED MODALITY THERAPY;
CYCLOPHOSPHAMIDE;
DACARBAZINE;
DOXORUBICIN;
FEMALE;
FEMORAL NEOPLASMS;
FIBULA;
HUMAN;
HUMERUS;
LUNG NEOPLASMS;
MALE;
METHOTREXATE;
MITOMYCIN;
MITOMYCINS;
OSTEOSARCOMA;
PROGNOSIS;
RADIOTHERAPY DOSAGE;
TIBIA;
TIME FACTORS;
VINCRISTINE;
|
EID: 0023855174
PISSN: 0008543X
EISSN: 10970142
Source Type: Journal
DOI: 10.1002/1097-0142(19880401)61:7<1304::AID-CNCR2820610705>3.0.CO;2-I Document Type: Article |
Times cited : (49)
|
References (20)
|